Griffith Peter H. 4
4 · AMGEN INC · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Amgen (AMGN) CFO Peter H. Griffith Surrenders 5,748 Shares for Taxes
What Happened
Peter H. Griffith, EVP & CFO of Amgen Inc., disposed of 5,748 shares on March 16, 2026 to satisfy a tax withholding obligation related to equity compensation. The shares were credited/valued at $366.21 each, for a total value of approximately $2,104,975. This transaction is reported under code F (payment of exercise price or tax liability).
Key Details
- Transaction date and price: March 16, 2026 — 5,748 shares at $366.21 each (total ≈ $2,104,975).
- Shares owned after transaction: Not specified in this Form 4 filing.
- Footnote: 756 of the shares were Dividend Equivalents (DEs) credited to unvested Restricted Stock Units under Amgen’s equity plan; DEs are paid out in shares on a one-for-one basis per the vesting schedule (plus cash for fractional shares).
- Filing/timeliness: Form 4 filed March 18, 2026 for a March 16 transaction — filed within the standard reporting window.
Context
This was a share surrender to cover tax obligations on equity compensation (a routine administrative disposition), not an open-market sale intended to express a view on the stock. For retail investors, tax-withholding dispositions are common after vesting and are generally less informative about insider sentiment than outright purchases.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-16$366.21/sh−5,748$2,104,975→ 49,001 total
Footnotes (1)
- [F1]These shares include 756 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.